Full Text
PDG35 COST-EFFECTIVENESS ANALYSIS OF LOW-DOSE RIVAROXABAN PLUS ASPIRIN FOR THE PATIENTS WITH STABLE CARDIOVASCULAR DISEASE IN TAIWAN SETTING

Abstract

Authors

M.C. Lee C.T. Liao H.S. Toh L. Sun W.T. Chang H.C. Su

Back to Volume 22, Supplemental S2
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×